155 related articles for article (PubMed ID: 29965883)
1. Influence of Sex, Age, and Weight on Levetiracetam Pharmacokinetics.
Alzueta N; Ortega A; Aldaz A
Ther Drug Monit; 2018 Oct; 40(5):628-634. PubMed ID: 29965883
[TBL] [Abstract][Full Text] [Related]
2. Influence of Comedication on Levetiracetam Pharmacokinetics.
Aldaz A; Alzueta N; Viteri C
Ther Drug Monit; 2018 Feb; 40(1):130-134. PubMed ID: 29210977
[TBL] [Abstract][Full Text] [Related]
3. Effect of age and comedication on levetiracetam pharmacokinetics and tolerability.
Hirsch LJ; Arif H; Buchsbaum R; Weintraub D; Lee J; Chang JT; Resor SR; Bazil CW
Epilepsia; 2007 Jul; 48(7):1351-9. PubMed ID: 17573925
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic Drug Monitoring of Levetiracetam in Select Populations.
Jarvie D; Mahmoud SH
J Pharm Pharm Sci; 2018; 21(1s):149s-176s. PubMed ID: 30096051
[TBL] [Abstract][Full Text] [Related]
5. Population pharmacokinetics and dose-response relationship of levetiracetam in adult patients with epilepsy.
Rhee SJ; Shin JW; Lee S; Moon J; Kim TJ; Jung KY; Park KI; Lee ST; Jung KH; Yu KS; Jang IJ; Chu K; Lee SK
Epilepsy Res; 2017 May; 132():8-14. PubMed ID: 28279893
[TBL] [Abstract][Full Text] [Related]
6. Levetiracetam clinical pharmacokinetics in elderly and very elderly patients with epilepsy.
Contin M; Mohamed S; Albani F; Riva R; Baruzzi A
Epilepsy Res; 2012 Feb; 98(2-3):130-4. PubMed ID: 21944894
[TBL] [Abstract][Full Text] [Related]
7. Levetiracetam circulating concentrations and response in status epilepticus.
Perrenoud M; André P; Buclin T; Decosterd LA; Rossetti AO; Novy J
Epilepsy Behav; 2018 Nov; 88():61-65. PubMed ID: 30241055
[TBL] [Abstract][Full Text] [Related]
8. The influence of old age and enzyme inducing comedication on the pharmacokinetics of valproic acid at steady-state: A case-matched evaluation based on therapeutic drug monitoring data.
Fattore C; Messina S; Battino D; Croci D; Mamoli D; Perucca E
Epilepsy Res; 2006 Aug; 70(2-3):153-60. PubMed ID: 16730950
[TBL] [Abstract][Full Text] [Related]
9. Topiramate pharmacokinetics in children and adults with epilepsy: a case-matched comparison based on therapeutic drug monitoring data.
Battino D; Croci D; Rossini A; Messina S; Mamoli D; Perucca E
Clin Pharmacokinet; 2005; 44(4):407-16. PubMed ID: 15828853
[TBL] [Abstract][Full Text] [Related]
10. Population Pharmacokinetic Modeling of Levetiracetam in Pediatric and Adult Patients With Epilepsy by Using Routinely Monitored Data.
Ito S; Yano I; Hashi S; Tsuda M; Sugimoto M; Yonezawa A; Ikeda A; Matsubara K
Ther Drug Monit; 2016 Jun; 38(3):371-8. PubMed ID: 26913593
[TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetics of extended-release levetiracetam in epileptic dogs when administered alone, with phenobarbital or zonisamide.
Muñana KR; Otamendi AJ; Nettifee JA; Papich MG
J Vet Intern Med; 2018 Sep; 32(5):1677-1683. PubMed ID: 30238679
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic Drug Monitoring of Levetiracetam and Lamotrigine: Is There a Need?
Naik GS; Kodagali R; Mathew BS; Thomas M; Prabha R; Mathew V; Fleming DH
Ther Drug Monit; 2015 Aug; 37(4):437-44. PubMed ID: 25478905
[TBL] [Abstract][Full Text] [Related]
13. Population pharmacokinetics of levetiracetam and dosing recommendation in children with epilepsy.
Chhun S; Jullien V; Rey E; Dulac O; Chiron C; Pons G
Epilepsia; 2009 May; 50(5):1150-7. PubMed ID: 19175400
[TBL] [Abstract][Full Text] [Related]
14. An investigation of the influence of patient-related factors and comedications on lamotrigine clearance in patients with epilepsy.
Baldoni AO; Freitas-Lima P; de Santi Ferreira FI; Martinez EZ; Queiroz RH; Sakamoto AC; Alexandre V; Perucca E; Pereira LR
Clin Exp Pharmacol Physiol; 2016 Jul; 43(7):685-9. PubMed ID: 27120710
[TBL] [Abstract][Full Text] [Related]
15. Review on the relevance of therapeutic drug monitoring of levetiracetam.
Sourbron J; Chan H; Wammes-van der Heijden EA; Klarenbeek P; Wijnen BFM; de Haan GJ; van der Kuy H; Evers S; Majoie M
Seizure; 2018 Nov; 62():131-135. PubMed ID: 30237016
[TBL] [Abstract][Full Text] [Related]
16. Population pharmacokinetics and dosing regimen optimization of levetiracetam in epilepsy during pregnancy.
Li Y; Wang ML; Guo Y; Cao YF; Zhao MM; Zhao LM
Br J Clin Pharmacol; 2023 Mar; 89(3):1152-1161. PubMed ID: 36260320
[TBL] [Abstract][Full Text] [Related]
17. Influence of aging on serum phenytoin concentrations: a pharmacokinetic analysis based on therapeutic drug monitoring data.
Battino D; Croci D; Mamoli D; Messina S; Perucca E
Epilepsy Res; 2004; 59(2-3):155-65. PubMed ID: 15246117
[TBL] [Abstract][Full Text] [Related]
18. Effect of chronic administration of phenobarbital, or bromide, on pharmacokinetics of levetiracetam in dogs with epilepsy.
Muñana KR; Nettifee-Osborne JA; Papich MG
J Vet Intern Med; 2015; 29(2):614-9. PubMed ID: 25711374
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic Monitoring of Levetiracetam in Portuguese Refractory Epileptic Patients: Effect of Gender, Weight and Concomitant Therapy.
Silva R; Almeida A; Bicker J; Gonçalves J; Carona A; Silva A; Santana I; Sales F; Falcão A; Fortuna A
Pharmaceutics; 2020 Oct; 12(10):. PubMed ID: 33019727
[TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetics of levetiracetam in neonates with seizures.
Lima-Rogel V; López-López EJ; Medellín-Garibay SE; Gómez-Ruiz LM; Romero-Méndez C; Milán-Segovia RC; Romano-Moreno S
J Clin Pharm Ther; 2018 Jun; 43(3):422-429. PubMed ID: 29265480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
